SLC34A2 and neoplasm: The multivariate analysis of the CNS and brain cancer dataset showed that the level of SLC34A2 mRNA expression has a hazard ratio of 2.07 (CI: 0.99–4.3; Supplementary Figure S1C); the parameter with a higher hazard ratio was only Neoplasm Disease Lymph Node Stage N3.